Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Prostatectomy
  • Prostatic Neoplasms

abstract

  • Although our study was not originally powered to detect differences in BCR, there was no overall benefit in BCR-free probability, local recurrence or metastasis with 3 months of NHT at 8 years of follow-up. Pending evidence of improvement in patient outcomes, NHT before RP appears to be unjustified outside of clinical trials.

publication date

  • January 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2807908

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2009.08698.x

PubMed ID

  • 19594741

Additional Document Info

start page

  • 185

end page

  • 90

volume

  • 105

number

  • 2